期刊文献+

急性缺血性脑卒中患者CRP、TNF-α的变化及辛伐他汀抗炎作用研究 被引量:15

Study on the changes of C reactive protein and TNF-α in patients with acute ischemic stroke and anti-inflammation of Simvastatin
暂未订购
导出
摘要 目的探讨急性脑卒中与炎症反应的关系及辛伐他汀对脑损伤的保护作用。方法将急性缺血性脑卒中患者42例随机分为2组:A组17例,B组25例。另选择30例健康体检者作为C组。A组给予常规治疗,B组在常规治疗基础上给予辛伐他汀治疗。检测3组入院时及A组、B组治疗2周后CRP、TNF-α水平,并比较轻、中、重型患者CRP和TNF-α水平。结果 A组、B组治疗前CRP、TNF-α水平明显高于C组。治疗2周后,A组CRP、TNF-α亦明显高于C组;B组CRP水平低于A组,与C组相比无显著性差异;B组TNF-α水平与C组相比有显著性差异。轻型脑卒中组CRP和TNF-α水平均明显高于C组;中型脑卒中组CRP水平明显高于轻型脑卒中组,TNF-α2组无显著性差异;轻型脑卒中组、中型脑卒中组与重型脑卒中组CRP和TNF-α比较均有显著性差异。结论炎症与急性脑卒中的发生具有明确的相关性,炎症反应是急性脑卒中发病的一个重要危险因素。辛伐他汀除有调节血脂作用外,还具有抗炎作用。 Objective It is to explore the relationship between inflammation and acute ischemic stroke and to explore the protecting effect of Simvastatin on cerebral injury.Methods 42 subjects with cerebral infarction were randomly divided into two groups: group A with 17 cases and group B with 25 cases.In addition,30 normal persons after a general health examination were chosen as control group(group C).Group A was treated with normal method,group B was given Simvastatin based on normal treatment.The levels of C reactive protein(CRP) and TNF-α of the three groups being hospital and those of group A and B after two weeks' treatment were determined,and the levels were compared among the patients of light,moderate and severe type.Results The level of CRP and TNF-α before treatment in group A and group B was significantly higher than those in group C.After two weeks' treatment,the levels of those factors in group A were also higher than that in the control group,the level of CRP in group B was lower than that of group A,but compared with the control group,the difference was not significant.The level of TNF-α in group B was significant higher than that in group C.The levels of CRP and TNF-α in light stroke group were significantly higher than those in control group.The level of CRP in medium stroke group was significantly higher than that in light stroke group,but the level of TNF-α had no significant difference between two groups.The level of CRP and TNF-α in light and moderate groups compared with serious group had significant difference.Conclusion Inflammation has a strong association with ischemic stroke and inflammation reaction is an important risk factor of ischemic stroke.Simvastatin not only has improving effect on blood fat,but also has anti-inflammation.
出处 《现代中西医结合杂志》 CAS 2011年第13期1564-1565,1576,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 河北省卫生厅立项课题(05422)
关键词 急性脑卒中 炎症反应 C反应蛋白 肿瘤坏死因子-Α 动脉粥样硬化 acute ischemic stroke inflammatory reaction C reactive protein tumor necrosis factor-α atherosclerosis
  • 相关文献

参考文献9

  • 1Pasceri V ,Chang J,Willerson JT,et al. Modulation of ereactive protein mediated monocy techemo attractant protein linduction in human endothelial cells by antiatheroselerosis drugs[ J]. Circulation, 2001,103:2531 - 534.
  • 2Maseri A. Inflammation, atherosis and ischemic evenls xplving the hidden side of the moon [ J]. N Engl Jrned, 1997,336 : 1014 - 1016.
  • 3应红宇,丁仁瑞.TNF的生物学功能与受体的信号传导[J].中国肿瘤生物治疗杂志,1995,2(3):222-226. 被引量:6
  • 4卢冬喜 卢光增.C反应蛋白与缺血性卒中的结局.国外医学:脑血管疾病分册,2000,:48-48.
  • 5Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, Pravastatin, and the risk of coronary after myocardial infarctino in patients with avcrage cholester ollerels [ J ]. Circulation, 1998,98 ( 8 ) :499.
  • 6Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor a expression in ischemic neurons[J]. Stroke,1994,25(7):1481 -1488.
  • 7Kochanek PM, Hallenbeck JM. Polymorphonuclear leukoeytes and monoeytest maerophages in the pathogenesis of eerebralis ehemia and stroke [ J ]. Stroke, 1992,23 : 1367.
  • 8Lavine SD,Hofman FM,Zlokovic BV. Circulation gantibody against tumor necrosis factor -t protects rat brain from reperfusion injury [ J ]. Jcereb Blood Flow Metab, 1998,18 ( 1 ) :52 - 58.
  • 9温红梅.C反应蛋白与缺血性卒中[J].国外医学(脑血管疾病分册),2002,10(4):298-300. 被引量:102

二级参考文献22

  • 1万晓余,吴淑华.肿瘤坏死因子结构研究进展[J].生物化学与生物物理进展,1993,20(5):351-356. 被引量:6
  • 2Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor.more than an epiphenomenon? Circulation,1999, 100(1 ): 96-102.
  • 3Tracy RP. Inflammation in cardiovascular disease: cart, horse, or both.? Circulation, 1998, 97(20): 2000-2002.
  • 4Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem, 1999, 45 (12):2136-2141.
  • 5Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem, 2001,47(3):418-425.
  • 6Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.Clin Chem, 2001,47(3): 426-430.
  • 7Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin,and the risk of cardiovascular disease in apparently healthy men. N Engl J Med, 1997, 336(14): 973-979.
  • 8Di Napoli M, Di Gianfilippa G, Sollecito A, et al. C-reactive protein and outcome after first-ever ischemic stroke. Stroke, 2000, 31 (1):238-239.
  • 9Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke,2001,32(1): 133-138.
  • 10Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke, 2001, 32(4): 917-924.

共引文献106

同被引文献156

引证文献15

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部